Senomorphics represent a novel approach in cancer therapy by potentially reducing the pro-tumorigenic effects of senescent cells. By modulating SASP, senomorphics can decrease inflammation and tumor-promoting signals, potentially inhibiting cancer progression and improving the efficacy of existing treatments.
